Skip to main content
Veterinary Medicines

Denagard 10% 100 mg/g Premiks do sporządzania paszy leczniczej

Authorised
  • Tiamulin hydrogen fumarate

Product identification

Medicine name:
Denagard 10% 100 mg/g Premiks do sporządzania paszy leczniczej
Active substance:
  • Tiamulin hydrogen fumarate
Target species:
  • Pig
  • Turkey
  • Chicken (hen)
  • Rabbit
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        6
        day
    • Turkey
      • Meat and offal
        4
        day
    • Chicken (hen)
      • Meat and offal
        1
        day
      • Eggs
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
  • Andres Pintaluba S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0493
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."